Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001347613-17-000003
Filing Date
2017-03-01
Accepted
2017-03-01 17:12:12
Documents
69
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sgyp-123116x10k.htm 10-K 1631170
2 EXHIBIT 3.4 synergyamendedandrestatedb.htm EX-3.4 92050
3 EXHIBIT 4.12 synergypharmaceuticals-sup.htm EX-4.12 21994
4 EXHIBIT 10.3 a12-2016sgypjacobexempxfif.htm EX-10.3 86133
5 EXHIBIT 14 synergycodeofbusinesscondu.htm EX-14 180755
6 EXHIBIT 21 exhibit21.htm EX-21 3050
7 EXHIBIT 23 a5_09-sx3consent.htm EX-23 3674
8 EXHIBIT 31.1 copyofsgyp-ex311x93016x10q.htm EX-31.1 14649
9 EXHIBIT 31.2 copyofsgyp-ex312x93016x10q.htm EX-31.2 14708
10 EXHIBIT 32.1 copyofsgyp-ex321x93016x10q.htm EX-32.1 6431
11 EXHIBIT 32.2 copyofsgyp-ex322x93016x10q.htm EX-32.2 7081
18 picture3a01.jpg GRAPHIC 78280
19 TOTAL RETURN GRAPH sgyp2016totalreturn.jpg GRAPHIC 98716
  Complete submission text file 0001347613-17-000003.txt   7956517

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT sgyp-20161231.xml EX-101.INS 1459101
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20161231.xsd EX-101.SCH 53418
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20161231_cal.xml EX-101.CAL 73105
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20161231_def.xml EX-101.DEF 269756
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgyp-20161231_lab.xml EX-101.LAB 674623
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20161231_pre.xml EX-101.PRE 398413
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35268 | Film No.: 17655390
SIC: 2834 Pharmaceutical Preparations